Johnson & Johnson Boosts Full-Year Forecast
October 13 2020 - 7:35AM
Dow Jones News
By Matt Grossman
Johnson & Johnson Tuesday revised its full-year forecast,
pointing to slightly higher sales and profit figures than the
company had previously indicated.
J&J said it now estimates 2020 reported sales will be
between $81.2 billion and $82 billion, which represents a range of
a 1% decline to flat compared with last year's results. In July,
J&J said it expected reported sales to decline between 0.8% and
2.6% year over year.
The New Brunswick, N.J.-based health-care company said it now
expects adjusted earnings per share of between $7.95 and $8.05 for
the full year. The company had previously forecast adjusted
earnings per share of $7.75 to $7.95.
Write to Matt Grossman at matt.grossman@wsj.com
(END) Dow Jones Newswires
October 13, 2020 07:20 ET (11:20 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Apr 2023 to Apr 2024
